Literature DB >> 24126592

Polycystic kidney disease: TGF-β signalling and vascular complications in ADPKD.

Ellen F Carney.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24126592     DOI: 10.1038/nrneph.2013.214

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  1 in total

1.  A Pkd1-Fbn1 genetic interaction implicates TGF-β signaling in the pathogenesis of vascular complications in autosomal dominant polycystic kidney disease.

Authors:  Dongyan Liu; Connie J Wang; Daniel P Judge; Marc K Halushka; Jie Ni; Jennifer P Habashi; Javid Moslehi; Djahida Bedja; Kathleen L Gabrielson; Hangxue Xu; Feng Qian; David Huso; Harry C Dietz; Gregory G Germino; Terry Watnick
Journal:  J Am Soc Nephrol       Date:  2013-09-26       Impact factor: 10.121

  1 in total
  3 in total

1.  Antisense-mediated angiotensinogen inhibition slows polycystic kidney disease in mice with a targeted mutation in Pkd2.

Authors:  Kameswaran Ravichandran; Abdullah Ozkok; Qian Wang; Adam E Mullick; Charles L Edelstein
Journal:  Am J Physiol Renal Physiol       Date:  2014-12-23

2.  Inhibition of MiR-199a-5p reduced cell proliferation in autosomal dominant polycystic kidney disease through targeting CDKN1C.

Authors:  Lijun Sun; Jiaqi Zhu; Ming Wu; Haipeng Sun; Chenchen Zhou; Lili Fu; Chenggang Xu; Changlin Mei
Journal:  Med Sci Monit       Date:  2015-01-15

3.  Renal expression of JAK2 is high in polycystic kidney disease and its inhibition reduces cystogenesis.

Authors:  Foteini Patera; Alex Cudzich-Madry; Zhi Huang; Maria Fragiadaki
Journal:  Sci Rep       Date:  2019-03-14       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.